Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
Dehn H, Høgdall EV, Johansen JS, Jørgensen M, Price PA, Engelholm SA, Høgdall CK. Dehn H, et al. Among authors: hogdall ev, hogdall ck. Acta Obstet Gynecol Scand. 2003 Mar;82(3):287-93. doi: 10.1034/j.1600-0412.2003.00010.x. Acta Obstet Gynecol Scand. 2003. PMID: 12694127 Free article.
Pre-treatment prediction of chemoresistance in second-line chemotherapy of ovarian carcinoma: value of serological tumor marker determination (tetranectin, YKL-40, CASA, CA 125).
Gronlund B, Høgdall EV, Christensen IJ, Johansen JS, Nørgaard-Pedersen B, Engelholm SA, Høgdall C. Gronlund B, et al. Among authors: hogdall ev, hogdall c. Int J Biol Markers. 2006 Jul-Sep;21(3):141-8. doi: 10.1177/172460080602100302. Int J Biol Markers. 2006. PMID: 17013795 Free article.
YKL-40 tissue expression and plasma levels in patients with ovarian cancer.
Høgdall EV, Ringsholt M, Høgdall CK, Christensen IJ, Johansen JS, Kjaer SK, Blaakaer J, Ostenfeld-Møller L, Price PA, Christensen LH. Høgdall EV, et al. Among authors: hogdall ck. BMC Cancer. 2009 Jan 9;9:8. doi: 10.1186/1471-2407-9-8. BMC Cancer. 2009. PMID: 19134206 Free PMC article.
Tissue microRNAs as predictors of outcome in patients with metastatic colorectal cancer treated with first line Capecitabine and Oxaliplatin with or without Bevacizumab.
Boisen MK, Dehlendorff C, Linnemann D, Nielsen BS, Larsen JS, Osterlind K, Nielsen SE, Tarpgaard LS, Qvortrup C, Pfeiffer P, Holländer NH, Keldsen N, Hansen TF, Jensen BB, Høgdall EV, Jensen BV, Johansen JS. Boisen MK, et al. Among authors: hogdall ev. PLoS One. 2014 Oct 15;9(10):e109430. doi: 10.1371/journal.pone.0109430. eCollection 2014. PLoS One. 2014. PMID: 25329796 Free PMC article.
122 results